+
+

Related Products

  • SciSure
    298 Ratings
    Visit Website
  • AlisQI
    96 Ratings
    Visit Website
  • RaimaDB
    12 Ratings
    Visit Website
  • Bitrise
    396 Ratings
    Visit Website
  • Curbside Laundries
    63 Ratings
    Visit Website
  • Teradata VantageCloud
    1,120 Ratings
    Visit Website
  • Coursebox AI
    98 Ratings
    Visit Website
  • LTX
    181 Ratings
    Visit Website
  • Careerminds
    46 Ratings
    Visit Website
  • Paligo
    99 Ratings
    Visit Website

About

BioNeMo is an AI-powered drug discovery cloud service and framework built on NVIDIA NeMo Megatron for training and deploying large biomolecular transformer AI models at a supercomputing scale. The service includes pre-trained large language models (LLMs) and native support for common file formats for proteins, DNA, RNA, and chemistry, providing data loaders for SMILES for molecular structures and FASTA for amino acid and nucleotide sequences. The BioNeMo framework will also be available for download for running on your own infrastructure. ESM-1, based on Meta AI’s state-of-the-art ESM-1b, and ProtT5 are transformer-based protein language models that can be used to generate learned embeddings for tasks like protein structure and property prediction. OpenFold, a deep learning model for 3D structure prediction of novel protein sequences, will be available in BioNeMo service.

About

Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Organizations looking for a powerful Drug Discovery solution

Audience

Recursion is ideal for researchers, pharmaceutical partners, investors, and healthcare stakeholders interested in AI-driven drug discovery and next-generation therapeutic development

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

NVIDIA
Founded: 1993
United States
www.nvidia.com/en-us/gpu-cloud/bionemo/

Company Information

Recursion
United States
www.recursion.com

Alternatives

Alternatives

ESMFold2

ESMFold2

Biohub
ESMC

ESMC

Biohub
AlphaFold

AlphaFold

DeepMind

Categories

Categories

Integrations

Evo 2
NVIDIA AI Foundations
NVIDIA Clara
NVIDIA NeMo Megatron

Integrations

Evo 2
NVIDIA AI Foundations
NVIDIA Clara
NVIDIA NeMo Megatron
Claim NVIDIA BioNeMo and update features and information
Claim NVIDIA BioNeMo and update features and information
Claim Recursion and update features and information
Claim Recursion and update features and information